RAPT Therapeutics Beheer
Beheer criteriumcontroles 2/4
De CEO RAPT Therapeutics is Brian Wong, benoemd in Aug2015, heeft een ambtstermijn van 9.25 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 6.59M, bestaande uit 9.2% salaris en 90.8% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 1.41% van de aandelen van het bedrijf, ter waarde $ 527.10K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 4.8 jaar en 7.5 jaar.
Belangrijke informatie
Brian Wong
Algemeen directeur
US$6.6m
Totale compensatie
| Percentage CEO-salaris | 9.2% |
| Dienstverband CEO | 9.3yrs |
| Eigendom CEO | 1.4% |
| Management gemiddelde ambtstermijn | 4.8yrs |
| Gemiddelde ambtstermijn bestuur | 7.5yrs |
Recente managementupdates
Recent updates
Can RAPT Therapeutics (NASDAQ:RAPT) Afford To Invest In Growth?
Nov 10
RAPT: CCR4 Inhibition Presses On For Now With Oncology Focus
Jul 24Companies Like RAPT Therapeutics (NASDAQ:RAPT) Could Be Quite Risky
Jun 13RAPT Therapeutics: Dip Following FDA Clinical Hold Creates Asymmetric Opportunity
May 20Is RAPT Therapeutics (NASDAQ:RAPT) In A Good Position To Invest In Growth?
Feb 21We Think RAPT Therapeutics (NASDAQ:RAPT) Can Afford To Drive Business Growth
Sep 12We Think RAPT Therapeutics (NASDAQ:RAPT) Can Afford To Drive Business Growth
May 10We're Hopeful That RAPT Therapeutics (NASDAQ:RAPT) Will Use Its Cash Wisely
Feb 07We're Hopeful That RAPT Therapeutics (NASDAQ:RAPT) Will Use Its Cash Wisely
Oct 12RAPT Therapeutics (NASDAQ:RAPT) Is In A Good Position To Deliver On Growth Plans
Jan 25RAPT Therapeutics (NASDAQ:RAPT) Is In A Good Position To Deliver On Growth Plans
Oct 15RAPT Therapeutics (RAPT) skyrockets 100% on positive RPT193 data in early-stage atopic dermatitis study
Jun 14RAPT Therapeutics (NASDAQ:RAPT) Is In A Good Position To Deliver On Growth Plans
Jun 08Should You Take Comfort From Insider Transactions At RAPT Therapeutics, Inc. (NASDAQ:RAPT)?
Mar 15We Think RAPT Therapeutics (NASDAQ:RAPT) Can Easily Afford To Drive Business Growth
Feb 15
RAPT Therapeutics' (NASDAQ:RAPT) Stock Price Has Reduced 56% In The Past Year
Jan 18RAPT Therapeutics: Interesting Asset, But Doubtful History And Bad Market Reaction
Jan 08Here's What RAPT Therapeutics, Inc.'s (NASDAQ:RAPT) Shareholder Ownership Structure Looks Like
Dec 21The Independent Chairman of the Board of RAPT Therapeutics, Inc. (NASDAQ:RAPT), William Rieflin, Just Bought 12% More Shares
Nov 23Earnings Beat: RAPT Therapeutics, Inc. (NASDAQ:RAPT) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Nov 19Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$107m |
| Jun 30 2024 | n/a | n/a | -US$120m |
| Mar 31 2024 | n/a | n/a | -US$118m |
| Dec 31 2023 | US$7m | US$605k | -US$117m |
| Sep 30 2023 | n/a | n/a | -US$109m |
| Jun 30 2023 | n/a | n/a | -US$99m |
| Mar 31 2023 | n/a | n/a | -US$93m |
| Dec 31 2022 | US$5m | US$580k | -US$84m |
| Sep 30 2022 | n/a | n/a | -US$79m |
| Jun 30 2022 | n/a | n/a | -US$76m |
| Mar 31 2022 | n/a | n/a | -US$73m |
| Dec 31 2021 | US$3m | US$540k | -US$69m |
| Sep 30 2021 | n/a | n/a | -US$64m |
| Jun 30 2021 | n/a | n/a | -US$60m |
| Mar 31 2021 | n/a | n/a | -US$56m |
| Dec 31 2020 | US$4m | US$500k | -US$53m |
| Sep 30 2020 | n/a | n/a | -US$53m |
| Jun 30 2020 | n/a | n/a | -US$49m |
| Mar 31 2020 | n/a | n/a | -US$47m |
| Dec 31 2019 | US$2m | US$447k | -US$43m |
| Sep 30 2019 | n/a | n/a | -US$39m |
| Jun 30 2019 | n/a | n/a | -US$40m |
| Mar 31 2019 | n/a | n/a | -US$37m |
| Dec 31 2018 | US$1m | US$425k | -US$36m |
Compensatie versus markt: De totale vergoeding ($USD 6.59M ) Brian } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 652.28K ).
Compensatie versus inkomsten: De vergoeding van Brian is gestegen terwijl het bedrijf verliesgevend is.
CEO
Brian Wong (52 yo)
9.3yrs
Tenure
US$6,591,617
Compensatie
Dr. Brian Russell Wong, M.D., Ph.D. serves as Venture Partner at The Column Group, LLC since joining the firm in 2022. He has been Chief Executive Officer and Director at RAPT Therapeutics, Inc. since Augu...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO, President & Director | 9.3yrs | US$6.59m | 1.41% $ 527.1k | |
| CFO, Principal Accounting Officer & Secretary | 4.9yrs | US$2.18m | 0.034% $ 12.6k | |
| Chief Medical Officer | 9.5yrs | US$1.90m | 0.045% $ 16.8k | |
| Vice President of Technology | no data | geen gegevens | geen gegevens | |
| Chief Scientific Officer | 5.4yrs | US$1.48m | 0.074% $ 27.6k | |
| General Counsel | 1.8yrs | geen gegevens | geen gegevens | |
| Chief Human Resources Officer | 2.5yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Quantitative & Computational Biology | 4.7yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Drug Discovery & Preclinical Development | 5.8yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Regulatory Affairs & Quality Assurance | 2.2yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Technical Operations | less than a year | geen gegevens | geen gegevens |
4.8yrs
Gemiddelde duur
57.5yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van RAPT wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.8 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO, President & Director | 9.3yrs | US$6.59m | 1.41% $ 527.1k | |
| Independent Chairman of the Board | 9.5yrs | US$300.28k | 0.27% $ 101.4k | |
| Independent Director | 4.9yrs | US$277.78k | 0% $ 0 | |
| Member of Scientific Advisory Board | 7.5yrs | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | 7.5yrs | geen gegevens | geen gegevens | |
| Chairman of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | 7.2yrs | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | 5.3yrs | geen gegevens | geen gegevens | |
| Independent Director | 6.8yrs | US$267.78k | 0% $ 0 | |
| Independent Director | 7.9yrs | US$260.78k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens |
7.5yrs
Gemiddelde duur
65yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van RAPT wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.5 jaar).